- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Biophytis announces transfer of ADSs to OTC Market following Nasdaq delisting | 2 | Seeking Alpha | ||
| Mi | Biophytis Announces Transfer of ADSs to OTC Market | 233 | ACCESSWIRE | ADSs delisted from Nasdaq, which will result in meaningful savingsADSs transferred to OTC Pink market; Company will apply to trade on OTCQB marketBiophytis remains listed on Euronext Growth Paris as... ► Artikel lesen | |
| Di | XFRA 6XB2: AUSSETZUNG/SUSPENSION | 57 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBIOPHYTIS ADR/4000... ► Artikel lesen | |
| Di | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.04.2024 | 180 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2024
Aktien
1 CA5854671032 Melcor Developments... ► Artikel lesen | |
| Mo | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.04.2024 | 311 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.04.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.04.2024ISIN NameAU0000220865 GCX... ► Artikel lesen | |
| Mo | XFRA ISIN CHANGE | 238 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA53681M2058 Lithium Lion Metals Inc. 22.04.2024 CA69867J1057 Lithium Lion Metals Inc. 23.04.2024 Tausch 1:1AU0000220865 GCX... ► Artikel lesen | |
| Mo | XFRA CAPITAL ADJUSTMENT INFORMATION - 22.04.2024 | 91 | Xetra Newsboard | Das Instrument 0PD GB00B1JQBT10 PINEWOOD TECH.GR. LS-,05 EQUITY wird cum Kapitalmassnahme gehandelt am 22.04.2024 und ex Kapitalmassnahme am 23.04.2024 The instrument 0PD GB00B1JQBT10 PINEWOOD TECH.GR.... ► Artikel lesen | |
| Fr | Biophytis Announces Ratio Change Under its American Depositary Receipt Program | 267 | ACCESSWIRE | PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 19, 2024 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized... ► Artikel lesen | |
| 18.04. | Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity | 277 | ACCESSWIRE | IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 18, 2024 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company")... ► Artikel lesen | |
| 15.04. | Biophytis SA - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.04. | Biophytis reports FY results | 3 | Seeking Alpha | ||
| 09.04. | Why Is Penny Stock Biophytis Trading Higher On Tuesday? | 4 | Benzinga.com | ||
| 09.04. | Why Is Biophytis (BPTS) Stock Up 43% Today? | 2 | InvestorPlace | ||
| 09.04. | Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up | 1 | Zacks | ||
| 09.04. | Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket | 3 | Benzinga.com | ||
| 09.04. | Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities | 375 | ACCESSWIRE | PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (NASDAQ:BPTS), (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized... ► Artikel lesen | |
| 08.04. | Biophytis launches OBA phase 2 clinical study in obesity with BIO101 | 505 | ACCESSWIRE | Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to start mid-2024PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext... ► Artikel lesen | |
| 08.04. | Biophytis SA - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
| 05.04. | Biophytis SA - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.04. | Biophytis: Results of the Combined General Meeting on April 2, 2024 | 266 | ACCESSWIRE | All resolutions presented by the Company have been adoptedPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 4, 2024 / Biophytis SA (NASDAQ:BPTS),(Euronext Growth Paris:ALBPS), ("Biophytis" or the... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 3,626 | +0,28 % | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy | Original-Research: Valneva - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva Unternehmen: Valneva ISIN: FR0004056851 Anlass der Studie: Update... ► Artikel lesen | |
| BIOFRONTERA | 0,334 | -3,47 % | PTA-NVR: Biofrontera AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG | DJ PTA-NVR: Biofrontera AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG
Gesamtstimmrechte gemäß § 41 WpHG
Leverkusen (pta/23.04.2024/19:57) - 1. Emittent Biofrontera AG,... ► Artikel lesen | |
| AAP IMPLANTATE | 0,920 | +12,88 % | aap Implantate: Kapitalerhöhung erfolgreich abgeschlossen | Bad Marienberg (www.anleihencheck.de) - Die aap Implantate AG ("aap" oder "Gesellschaft") (ISIN DE000A3H2101/ WKN A3H210) konnte erfolgreich die am 18. März 2024 angekündigte 10% Kapitalerhöhung unter... ► Artikel lesen | |
| MAINZ BIOMED | 0,821 | -1,32 % | Mainz Biomed Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| SANGAMO THERAPEUTICS | 0,470 | +1,71 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering | Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase... ► Artikel lesen | |
| SCORPIUS | 0,109 | 0,00 % | Scorpius Holdings, Inc.: Scorpius Holdings Announces Receipt of Filing Delinquency Notification | DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 19,975 | +0,99 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy | CAMBRIDGE, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based... ► Artikel lesen | |
| VIKING THERAPEUTICS | 59,52 | -2,07 % | Viking Therapeutics down 4% despite quarterly bottom line beat | ||
| REDHILL BIOPHARMA | 0,400 | +2,44 % | RedHill Biopharma Ltd. - 6-K, Report of foreign issuer | ||
| AMYRIS | 0,039 | 0,00 % | AMYRIS, INC. - 8-K, Current Report | ||
| BLUEBIRD BIO | 0,863 | -0,02 % | bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance | SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported fourth quarter and annual financial results and business highlights for the... ► Artikel lesen | |
| SAREPTA THERAPEUTICS | 110,85 | -4,56 % | This Is What Whales Are Betting On Sarepta Therapeutics | ||
| IBIO | 1,890 | 0,00 % | Pre-market Movers: iBio, Direct Digital Holdings, Nuvation Bio, PaySign, LuxUrban Hotels | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).In the Green iBio, Inc. (IBIO) is up over 86% at $2.14.
Nuvation... ► Artikel lesen | |
| BELLEROPHON THERAPEUTICS | 0,001 | -100,00 % | Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology; Athersys, Inc.; Borqs Technologies; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition; Evelo Biosciences ... | NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc. SmileDirectClub, Inc.'s securities were suspended on... ► Artikel lesen | |
| GERON | 3,312 | -0,87 % | Geron Announces Pricing Of $150 Mln Underwritten Offering Of Common Stock, Pre-Funded Warrants | WASHINGTON (dpa-AFX) - Tuesday, Geron Corp. (GERN) disclosed the pricing of an underwritten offering and pre-funded warrants. The offering comprises 41,999,998 shares of its common stock at... ► Artikel lesen |
BIOPHYTIS ADR gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,224 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
